公开(公告)号：US20190144417A1

公开(公告)日：2019-05-16

申请号：US16098245

申请日：2017-05-04

Applicant: BRISTOL-MYERS SQUIBB COMPANY

Inventor： David K. WILLIAMS ,  Weifanq SHAN ,  Liping ZHANG ,  Emily Charlotte CHERNEY ,  James Aaron BALOG

IPC: C07D401/04 ,  A61P35/00 ,  C07D215/18 ,  A61K31/4709 ,  A61K31/47 ,  A61K31/496 ,  C07D401/06 ,  A61K31/444

Abstract: There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.